aTyr Pharma, Inc. (ATYR) Total Return Calculator with Dividends Reinvested

aTyr Pharma, Inc.

Popular:

The total return for aTyr Pharma, Inc. (ATYR) stock is -89.43% over the past 12 months. So far it's down 26.02% this year. The 5-year total return is -67.54%, meaning $10,000 invested in ATYR stock 5 years ago would be worth $3,246 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ATYR 1 year ago, it would be worth $1,076 today — you'd have lost $8,924.

With Dividends Reinvested$1,076-89.24%

Price Only (No DRIP)$1,076-89.24%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ATYR

1Y$1,057-$8,943 (-89.4%)-89.4% CAGR

3Y$3,246-$6,754 (-67.5%)-31.3% CAGR

5Y$3,246-$6,754 (-67.5%)-20.2% CAGR

10Y$3,246-$6,754 (-67.5%)-10.6% CAGR

15Y$3,246-$6,754 (-67.5%)-7.2% CAGR

20Y$3,246-$6,754 (-67.5%)-5.5% CAGR

30Y$3,246-$6,754 (-67.5%)-3.7% CAGR

aTyr Pharma, Inc. did not pay dividends during this period. Total return = price return.

Loading ATYR total return...

As of 2026-06-28

Performance Summary

Best Year+109.25%2024

Worst Year-79.97%2025

Max Drawdown-94.01%2025-07-23 → 2026-05-13

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-26.02%	—	-28.10%	+2.08 pp	$7,398
1Y	-89.43%	-89.43%	-89.72%	+0.30 pp	$1,057
3Y	-67.54%	-31.28%	-68.46%	+0.91 pp	$3,246
5Y	-67.54%	-20.15%	-68.46%	+0.91 pp	$3,246
10Y	-67.54%	-10.64%	-68.46%	+0.91 pp	$3,246
15Y	-67.54%	-7.23%	-68.46%	+0.91 pp	$3,246
20Y	-67.54%	-5.47%	-68.46%	+0.91 pp	$3,246
30Y	-67.54%	-3.68%	-68.46%	+0.91 pp	$3,246

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+26.46%	+26.46%	—	+0.41%	+26.0pp
2025	-79.97%	-79.97%	—	+16.64%	-96.6pp
2024	+109.25%	+109.25%	—	+24.00%	+85.2pp

ATYR underperformed the S&P 500 by 110.27pp over the past year (-89.43% vs +20.84%).

Loading summary...

ATYR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ATYRaTyr Pharma, Inc.	$54M	+12.7%	-26.0%	-89.4%	—	-67.5%	-67.5%	-67.5%
RAREUltragenyx Pharmaceutical Inc.	$3.0B	+33.0%	+23.3%	-21.7%	—	-40.1%	-68.8%	-40.8%
FOLDAmicus Therapeutics, Inc.	$4.5B	—	+1.5%	+153.8%	—	+20.0%	+41.4%	+165.9%
LGNDLigand Pharmaceuticals Incorporated	$6.1B	+29.0%	+49.9%	+141.0%	—	+294.3%	+110.8%	+154.9%
PRAXPraxis Precision Medicines, Inc.	$9.5B	-6.5%	+7.9%	+602.8%	—	+1824.9%	+5.4%	-25.9%
KYMRKymera Therapeutics, Inc.	$8.8B	+33.9%	+37.3%	+111.9%	—	+342.1%	+125.5%	+200.3%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%
ARWRArrowhead Pharmaceuticals, Inc.	$11.1B	+0.3%	+17.7%	+400.1%	—	+126.9%	-10.8%	+1359.1%
ALNYAlnylam Pharmaceuticals, Inc.	$38.9B	-1.4%	-26.5%	-9.5%	—	+53.7%	+69.3%	+441.4%
BEAMBeam Therapeutics Inc.	$3.6B	+16.9%	+24.9%	+97.7%	—	+6.0%	-63.9%	+80.8%
EDITEditas Medicine, Inc.	$279M	-7.5%	+36.6%	+24.4%	—	-65.0%	-93.1%	-89.3%

Compare:ATYR vs RARE ATYR vs FOLD ATYR vs LGND ATYR vs RARE vs FOLD

About ATYR Dividend Returns

aTyr Pharma, Inc. (ATYR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ATYR over the past year?

aTyr Pharma, Inc. (ATYR) delivered a return of -89.43% over the past year. Since ATYR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ATYR be worth today?

A $10,000 investment in aTyr Pharma, Inc. one year ago would be worth $1,057 today, representing a loss of $8,943.

Q3Does ATYR pay dividends?

aTyr Pharma, Inc. (ATYR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ATYR, the total return equals the price-only return.

Q4Did ATYR beat the S&P 500?

No, aTyr Pharma, Inc. (ATYR) underperformed the S&P 500 by 110.27 percentage points over the past year. ATYR delivered a total return of -89.43%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed ATYR by 110.27pp during this period.

Q5What is ATYR's worst drawdown?

aTyr Pharma, Inc. (ATYR) experienced a maximum drawdown of -94.01% over the past year, declining from its peak on 2025-07-23 to its trough on 2026-05-13. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ATYR's long-term total return over 10, 20, or 30 years?

Here are aTyr Pharma, Inc. (ATYR)'s long-term returns with dividends reinvested. Over 10 years, the total return is -67.5% (-10.6% CAGR) — $10,000 would have grown to $3,246. Over 20 years: -67.5% total return (-5.5% CAGR) — $10,000 → $3,246. Over 30 years: -67.5% total return (-3.7% CAGR) — $10,000 → $3,246. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ATYR's best and worst year?

aTyr Pharma, Inc.'s best calendar year was 2024 with a total return of 109.2%. Its worst year was 2025 with a total return of -80.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 189.2 percentage points.

How much would $100/month in ATYR be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →